Literature DB >> 7741567

Investigation and management of Clostridium difficile colonisation in a paediatric oncology unit.

I Schuller1, V Saha, L Lin, J Kingston, T Eden, S Tabaqchali.   

Abstract

Little is known about Clostridium difficile infection in children with cancer but a presumed outbreak has previously been described. The carriage rate before admission to hospital and morbidity is reported to be high, especially in younger children. The prevalence of C difficile infection on a paediatric oncology ward was monitored from June 1991 to May 1992. Twenty eight (13%) of 214 children were found to be infected. Though the temporal distribution suggested an outbreak, polyacrylamide gel electrophoresis identified several different types. Unlike previous reports, infection appeared to be possibly endogenous or possibly environmental in origin rather than due to cross infection; the morbidity was low and age was not a determinant for infection. The duration of hospital stay and the primary diagnosis were found to be determinants for infections, those with lymphoid malignancies being at the highest risk. The diagnostic category at greatest risk were those most intensively treated, with protracted neutropenia and prolonged antibiotic exposure. Early identification of cases and prompt institution of simple control measures will prevent cross infection. It is therefore important that diarrhoea is not accepted as a normal symptom of cancer chemotherapy and stool specimens are sent for full bacteriological and viral investigation.

Entities:  

Mesh:

Year:  1995        PMID: 7741567      PMCID: PMC1511071          DOI: 10.1136/adc.72.3.219

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  20 in total

1.  Clostridium difficile in an oncology unit.

Authors:  A L Brunetto; A D Pearson; A W Craft; S J Pedler
Journal:  Arch Dis Child       Date:  1988-08       Impact factor: 3.791

Review 2.  Clindamycin.

Authors:  A S Klainer
Journal:  Med Clin North Am       Date:  1987-11       Impact factor: 5.456

3.  Is Clostridium difficile endemic in chronic-care facilities?

Authors:  B S Bender; R Bennett; B E Laughon; W B Greenough; C Gaydos; S D Sears; M S Forman; J G Bartlett
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321

4.  Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy.

Authors:  B A Walters; R Roberts; R Stafford; E Seneviratne
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

5.  Typing scheme for Clostridium difficile: its application in clinical and epidemiological studies.

Authors:  S Tabaqchali; D Holland; S O'Farrell; R Silman
Journal:  Lancet       Date:  1984-04-28       Impact factor: 79.321

6.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

Review 7.  Occurrence and mechanisms of glycopeptide resistance in gram-positive cocci.

Authors:  V Saha; S Gupta; R S Daum
Journal:  Infect Agents Dis       Date:  1992-12

8.  Method for the typing of Clostridium difficile based on polyacrylamide gel electrophoresis of [35S]methionine-labeled proteins.

Authors:  S Tabaqchali; S O'Farrell; D Holland; R Silman
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

9.  Clostridium difficile infection in patients with haematological malignant disease. Risk factors, faecal toxins and pathogenic strains.

Authors:  S R Heard; B Wren; M J Barnett; J M Thomas; S Tabaqchali
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

10.  Association between production of toxins A and B and types of Clostridium difficile.

Authors:  B Wren; S R Heard; S Tabaqchali
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

View more
  9 in total

1.  Clostridium difficile-associated disease in children with solid tumors.

Authors:  Elio Castagnola; Teresa Battaglia; Roberto Bandettini; Ilaria Caviglia; Ivana Baldelli; Marilina Nantron; Cristina Moroni; Alberto Garaventa
Journal:  Support Care Cancer       Date:  2008-09-19       Impact factor: 3.603

2.  Differential yield of pathogens from stool testing of nosocomial versus community-acquired paediatric diarrhea.

Authors:  S Deorari; A McConnell; K K Tan; N Jadavji; D Ma; D Church; G Katzko; D G Gall; T Jadavji; H D Davies
Journal:  Can J Infect Dis       Date:  1999-11

3.  Pseudomembranous and neutropenic enterocolitis in pediatric oncology patients.

Authors:  M D van de Wetering; T W Kuijpers; J A J M Taminiau; F J W ten Kate; H N Caron
Journal:  Support Care Cancer       Date:  2003-05-24       Impact factor: 3.603

Review 4.  The impact of Clostridium difficile on paediatric surgical practice: a systematic review.

Authors:  D Mc Laughlin; F Friedmacher; P Puri
Journal:  Pediatr Surg Int       Date:  2014-07-10       Impact factor: 1.827

5.  Molecular epidemiology of Clostridium difficile strains in children compared with that of strains circulating in adults with Clostridium difficile-associated infection.

Authors:  Nicole Stoesser; Derrick W Crook; Rowena Fung; David Griffiths; Rosalind M Harding; Melina Kachrimanidou; Satish Keshav; Tim E Peto; Alison Vaughan; A Sarah Walker; Kate E Dingle
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

Review 6.  The role of Clostridium difficile in the paediatric and neonatal gut - a narrative review.

Authors:  E A Lees; F Miyajima; M Pirmohamed; E D Carrol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-23       Impact factor: 3.267

7.  Poorer outcomes among cancer patients diagnosed with Clostridium difficile infections in United States community hospitals.

Authors:  Andrew Delgado; Ivan A Reveles; Felicia T Cabello; Kelly R Reveles
Journal:  BMC Infect Dis       Date:  2017-06-23       Impact factor: 3.090

8.  Five years experience of Clostridium difficile infection in children at a UK tertiary hospital: proposed criteria for diagnosis and management.

Authors:  Sumita Pai; Sani Hussaini Aliyu; David Andrew Enoch; Johannis Andreas Karas
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

Review 9.  The association between histamine 2 receptor antagonist use and Clostridium difficile infection: a systematic review and meta-analysis.

Authors:  Imad M Tleyjeh; Aref Bin Abdulhak; Aref A Bin Abdulhak; Muhammad Riaz; Musa A Garbati; Mohamad Al-Tannir; Faisal A Alasmari; Mushabab Alghamdi; Abdur Rahman Khan; Patricia J Erwin; Alex J Sutton; Larry M Baddour
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.